The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies.
This article presents fluorodeoxyglucose PET/computed tomography for the evaluation of soft tissue sarcomas. Its clinical impact is discussed analyzing all the clinical information provided when applied in different phases of the disease. A special paragraph is dedicated to the use of functional imaging for driving the biopsy.